Month: April 2022

We expect to release the Q1 2022 results of DSV A/S in the morning of 27 April 2022. A webcast and conference call will be held at 11:00 am CEST. At the call, Group CEO Jens Bjørn Andersen, Group COO Jens Lund and Group CFO Michael Ebbe will present the Q1 2022 Interim Financial Report. The presentation will be followed by a Q&A session. Date:                 27 April 2022 Time:                 11:00 am CEST To attend the conference call, you may do one of the following:       a.   Webcast Go to investor.dsv.com or https://dsv-events.eventcdn.net/events/q1-2022-results       b.   Conference call Participant dial-in telephone numbers: DK: +45 78 76 84 90 UK: +44 (0) 203 769 6819 US: +1 646 787 0157 (PIN 88 26 86) No prior registration is required to attend the teleconference, but we recommend participants to dial in 10 minutes prior...

Tuesday, April 26, 2022 at 4:30 p.m. Eastern Time FREMONT, Calif., April 12, 2022 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference call and webcast on Tuesday, April 26, 2022 at 4:30 p.m. Eastern Time to discuss its first quarter 2022 financial results for the period ended March 31, 2022. The live webcast can be accessed on the Enphase Energy Investor Relations website at investor.enphase.com, and a recorded version of the call will also be available there approximately one hour after the call.What: Enphase Energy’s First Quarter 2022 Financial ResultsEarnings Conference Call and Webcast   Date: Tuesday, April 26, 2022   Time: 4:30 p.m. Eastern...

BASKING RIDGE, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, today announced that the first patient has been treated in its Phase 1b open-label, proof-of-concept study of CLBS201 for the treatment of diabetic kidney disease (“DKD”) at the Clinical Advancement Center in San Antonio, Texas. CLBS201 is an investigational autologous CD34+ cell therapy product for administration directly into the renal artery(ies) to reverse or slow the decline of renal function in diabetic patients with rapidly progressive chronic kidney disease (“CKD”). “With this trial, we hope to bring much improved patient outcomes to diabetic patients with reduced...

Accompanies Share Gains Across a Number of Other Critical Subsystems for Semiconductor Applications ANDOVER, Mass., April 12, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, is pleased to announce it became the global market leader in RF Power Supplies in 2021, as recently reported by TechInsights (formerly VLSI Research), an independent research and analytics firm. TechInsights also reported year over year share gains for MKS across a number of other critical subsystem categories, such as RF Power Matching Networks, Remote Plasma Sources, Pressure Sensing, Residual Gas Analyzers and Linear Motion Subsystems. 2021 marked another year of strong growth in industry spending on semiconductor capital equipment. Revenue from MKS’...

BLOOMINGTON, Ill., April 12, 2022 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company”), the holding company for Heartland Bank and Trust Company, today announced that it will issue its first quarter 2022 financial results before the market opens on Monday, April 25, 2022. A copy of the press release announcing the first quarter 2022 financial results and an investor presentation will be made available on the Company’s investor relations website at https://ir.hbtfinancial.com. About HBT Financial, Inc. HBT Financial, Inc., headquartered in Bloomington, Illinois, is the holding company for Heartland Bank and Trust Company, and has banking roots that can be traced back to 1920. HBT provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses...

  EXEL Industries A French Société Anonyme with a share capital of €16,969,750 Registered office:– France Reims Companies Register (RCS): No. 095 550 356   Number of shares and voting rights    Article 223-16 of the AMF regulation  Date Total number of shares comprising the share capital Total number of voting rightsFebruary 28, 2022 6,787,900 Theoretical voting rights : 10,854,334Exercisable voting rights* : 10,607,262* After deduction of shares without voting rights                            AttachmentEXEL Industries Droits de vote 2022.02.28_EN

Busy start to first quarter as a public company VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) — Amcomri Entertainment Inc. (“Amcomri” or the “Company”)) (NEO: AMEN) (Frankfurt: 25YO) is pleased to provide a progress report after completing its initial quarter as a publicly traded company. Amcomri, a global producer and distributor of independent movies, TV series and documentaries, underwent a major transformation during the first quarter of 2022. The Company closed a reverse takeover in early January and was listed for trading on the NEO Exchange in Toronto. “The reverse takeover of Appreciated Media and move to the NEO Exchange was quite a start to our year,” said Robert Price, CEO of Amcomri. “We had been negotiating the reverse takeover for more than 12 months, so it was gratifying to finally get it over the...